| Current strategies for inhibition of chikungunya infection BB Subudhi, S Chattopadhyay, P Mishra, A Kumar Viruses 10 (5), 235, 2018 | 91 | 2018 |
| High rates of co-infection of Dengue and Chikungunya virus in Odisha and Maharashtra, India during 2013 T Saswat, A Kumar, S Kumar, P Mamidi, S Muduli, NK Debata, NS Pal, ... Infection, Genetics and Evolution 35, 134-141, 2015 | 78 | 2015 |
| Inhibition of chikungunya virus replication by 1-[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea (MBZM-N-IBT) P Mishra, A Kumar, P Mamidi, S Kumar, I Basantray, T Saswat, I Das, ... Scientific reports 6 (1), 20122, 2016 | 73 | 2016 |
| Regulation of viral replication, apoptosis and pro-inflammatory responses by 17-AAG during Chikungunya virus infection in macrophages TK Nayak, P Mamidi, A Kumar, LPK Singh, SS Sahoo, S Chattopadhyay, ... Viruses 9 (1), 3, 2017 | 52 | 2017 |
| A novel 2006 Indian outbreak strain of Chikungunya virus exhibits different pattern of infection as compared to prototype strain A Kumar, P Mamidi, I Das, TK Nayak, S Kumar, J Chhatai, ... PloS one 9 (1), e85714, 2014 | 49 | 2014 |
| Development of novel antibodies against non-structural proteins nsP1, nsP3 and nsP4 of chikungunya virus: potential use in basic research S Kumar, P Mamidi, A Kumar, I Basantray, U Bramha, A Dixit, PK Maiti, ... Archives of virology 160, 2749-2761, 2015 | 28 | 2015 |
| Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity S Kumar, A Kumar, P Mamidi, A Tiwari, S Kumar, A Mayavannan, ... Scientific Reports 8 (1), 1045, 2018 | 26 | 2018 |
| Development and characterization of monoclonal antibody against non-structural protein-2 of Chikungunya virus and its application S Chattopadhyay, A Kumar, P Mamidi, TK Nayak, I Das, J Chhatai, ... Journal of virological methods 199, 86-94, 2014 | 25 | 2014 |
| Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7 HRL Yeong Jun Kim, Yuri Kim, Abhishek Kumar, Chan Woo Kim, Zsolt Toth, Nam ... Plos Pathogen 17, 2021 | 15 | 2021 |
| Signaling pathway reporter screen with SARS-CoV-2 proteins identifies nsp5 as a repressor of p53 activity A Kumar, TR Grams, DC Bloom, Z Toth Viruses 14 (5), 1039, 2022 | 13 | 2022 |
| MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway P Mamidi, TK Nayak, A Kumar, S Kumar, S Chatterjee, S De, A Datey, ... PLoS Pathogens 17 (11), e1009667, 2021 | 9 | 2021 |
| Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies A Kumar, S De, AK Moharana, TK Nayak, T Saswat, A Datey, P Mamidi, ... Virology Journal 18 (1), 103, 2021 | 9 | 2021 |
| Emergence of compensatory mutations reveals the importance of electrostatic interactions between HIV-1 integrase and genomic RNA C Shema Mugisha, T Dinh, A Kumar, K Tenneti, JE Eschbach, K Davis, ... MBio 13 (5), e00431-22, 2022 | 8 | 2022 |
| Editorial: New generation nano-biomaterials and their potential application in drug delivery and bio-sensing. S Das, B Panigrahi, SK Verma, A Kumar Front. Nanotechnol., 5 (Nanomaterial), 2023 | | 2023 |
| A COMPOSITION FOR INHIBITION OF INFECTION CAUSED BY CHIKUNGUNYA VIRUS (CHIKV) BB Subudhi, P Mishra, S Chattopadhyay, A Kumar IN Patent 347,150, 2020 | | 2020 |
Dr. Soma ChattopadhyayScientist-F, Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India - 751023在 ils.res.in 的电子邮件经过验证
